Literature DB >> 19685132

Atracurium during induced hyperthermia.

Gersten Jonker1, Leo J Hoogenboom, Bert van Ramshorst, Peter Bruins.   

Abstract

During hyperthermic intraperitoneal chemotherapy (HIPEC), we observed a partial recovery from neuromuscular block in a hyperthermic patient after hours of monitored adequate surgical relaxation and continuous infusion of atracurium during normothermia. This recovery is indicative of the higher clearance of atracurium during hyperthermia. This case report emphasizes the clinical relevance of the well-known temperature dependence of the Hofmann elimination of atracurium. Moreover, this report illustrates the importance of monitoring muscle relaxation during HIPEC. Clinicians should be aware that the usual continuous infusion rate of atracurium at 0.3 mg.kg(-1).h(-1) may be inadequate in hyperthermic patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19685132     DOI: 10.1007/s00540-009-0773-0

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  10 in total

1.  Duration of vecuronium-induced neuromuscular blockade is shortened during hyperthermic intraoperative intraperitoneal chemotherapy.

Authors:  Takehiko Adachi; Tetsutaro Shinomura; Ryoichi Nomura
Journal:  Br J Anaesth       Date:  2003-07       Impact factor: 9.166

2.  Atracurium in whole body hyperthermia.

Authors:  A Benzer; G Mitterschiffthaler; A Pomaroli; L Müller
Journal:  Anaesthesia       Date:  1990-11       Impact factor: 6.955

3.  Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium.

Authors:  J E Caldwell; T Heier; P M Wright; S Lin; G McCarthy; J Szenohradszky; M L Sharma; J P Hing; M Schroeder; D I Sessler
Journal:  Anesthesiology       Date:  2000-01       Impact factor: 7.892

Review 4.  Clinical pharmacokinetics of cisatracurium besilate.

Authors:  D F Kisor; V D Schmith
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

5.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

6.  Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C.

Authors:  V Fernández-Trigo; O A Stuart; A D Stephens; L D Hoover; P H Sugarbaker
Journal:  Cancer Treat Res       Date:  1996

7.  Use of atracurium infusions for general surgical procedures including cardiac surgery with induced hypothermia.

Authors:  P J Flynn; R Hughes; B Walton; S Jothilingam
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

8.  Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium.

Authors:  K Leslie; D I Sessler; A R Bjorksten; A Moayeri
Journal:  Anesth Analg       Date:  1995-05       Impact factor: 5.108

9.  Determination of continuous atracurium infusion rate in dogs undergoing whole-body hyperthermia.

Authors:  R E Meyer; R L Page; D E Thrall; M W Dewhirst; D L Vose
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

10.  Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination.

Authors:  D M Fisher; P C Canfell; M R Fahey; J I Rosen; S M Rupp; L B Sheiner; R D Miller
Journal:  Anesthesiology       Date:  1986-07       Impact factor: 7.892

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.